We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
9.48%
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Technology 6.61%
3 Industrials 5.39%
4 Communication Services 5.27%
5 Consumer Discretionary 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BH icon
1476
Biglari Holdings Class B
BH
$1.22B
$6K ﹤0.01%
+60
New +$7.17K
BHR
1477
Braemar Hotels & Resorts
BHR
$146M
$6K ﹤0.01%
+658
New +$7.81K
CNDT icon
1478
CALL
Conduent
CNDT
$271M
$6K ﹤0.01%
+600
New +$6.49K
CRESY
1479
Cresud
CRESY
$766M
$6K ﹤0.01%
+645
New +$6.21K
CRWD icon
1480
CrowdStrike
CRWD
$211B
$6K ﹤0.01%
+376
New +$6.39K
CYH icon
1481
Community Health Systems
CYH
$416M
$6K ﹤0.01%
2,418
+797
+49% +$2.52K
DB icon
1482
PUT
Deutsche Bank
DB
$70.7B
$6K ﹤0.01%
+800
New +$6.17K
EAF icon
1483
GrafTech
EAF
$199M
$6K ﹤0.01%
50
-1,540
-97% -$181K
FARM
1484
DELISTED
Farmer Brothers
FARM
$6K ﹤0.01%
+392
New +$7.47K
XRN
1485
Chiron Real Estate Inc
XRN
$469M
$6K ﹤0.01%
118
-678
-85% -$35.4K
HRTG icon
1486
Heritage Insurance Holdings
HRTG
$1.07B
$6K ﹤0.01%
+418
New +$6.15K
HSII
1487
DELISTED
Heidrick & Struggles
HSII
$6K ﹤0.01%
200
-1,895
-90% -$66.5K
KNSA icon
1488
Kiniksa Pharmaceuticals
KNSA
$5.97B
$6K ﹤0.01%
+425
New +$6.59K
LFCR icon
1489
Lifecore Biomedical
LFCR
$182M
$6K ﹤0.01%
+689
New +$6.96K
OPCH icon
1490
Option Care Health
OPCH
$3.54B
$6K ﹤0.01%
568
-16,616
-97% -$136K
PBH icon
1491
Prestige Consumer Healthcare
PBH
$2.58B
$6K ﹤0.01%
+200
New +$5.94K
R icon
1492
CALL
Ryder
R
$10.1B
$6K ﹤0.01%
+100
New +$5.95K
RMBS icon
1493
Rambus
RMBS
$10.6B
$6K ﹤0.01%
+500
New +$5.73K
SPRO icon
1494
Spero Therapeutics
SPRO
$73.5M
$6K ﹤0.01%
+500
New +$6.02K
STIM icon
1495
Neuronetics
STIM
$157M
$6K ﹤0.01%
+519
New +$7.33K
TBPH icon
1496
Theravance Biopharma
TBPH
$877M
$6K ﹤0.01%
+392
New +$7.94K
TRC icon
1497
Tejon Ranch
TRC
$444M
$6K ﹤0.01%
+379
New +$6.46K
AD
1498
Array Digital Infrastructure
AD
$3.08B
$6K ﹤0.01%
+131
New +$6.12K
QTTB icon
1499
Q32 Bio
QTTB
$482M
$6K ﹤0.01%
+18
New +$7.07K
ATSG
1500
DELISTED
Air Transport Services Group
ATSG
$6K ﹤0.01%
+256
New +$5.88K

Similar funds

Prelude Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.

  • Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
  • Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
  • Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
  • Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
  • Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
  • Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.